Diagnostic biomarkers are hidden in the infected host's epigenome

Expert Review of Molecular Diagnostics

Volumn 13, Issue 6, 2013, Pages 625-637

  Esterhuyse, Maria M ^a   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

DNA methylation; epigenome; histone modifications; immunity; infection; inflammation; plasticity; reprogramming

Indexed keywords

BIOLOGICAL MARKER;

DISEASE PREDISPOSITION; ENVIRONMENT; EPIGENETICS; HUMAN; IMMUNE SYSTEM; MEMORY; MOLECULAR DIAGNOSTICS; NONHUMAN; PLASTICITY; REVIEW; T LYMPHOCYTE; TREATMENT RESPONSE;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; INFECTION; NUCLEAR REPROGRAMMING; PATHOLOGY, MOLECULAR;

EID: 84881100840     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2013.811897     Document Type: Review

References (126)

1. Wong AH, Gottesman II, Petronis A. Phenotypic differences in genetically identical organisms: The epigenetic perspective. Hum. Mol. Genet. 14 (Spec No 1), R11-R18 (2005
2. Wolffe AP, Matzke MA. Epigenetics: Regulation through repression. Science 286(5439), 481-486 (1999
3. Zhu J, Adli M, Zou JY et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 152(3), 642-654 (2013
4. Mulero-Navarro S, Esteller M. Epigenetic biomarkers for human cancer: The time is now. Crit. Rev. Oncol. Hematol. 68(1), 1-11 (2008
5. Jopling C, Boue S, Izpisua Belmonte JC. Dedifferentiation, transdifferentiation and reprogramming: Three routes to regeneration. Nat. Rev. Mol. Cell Biol. 12(2), 79-89 (2011
6. Cantone I, Fisher AG. Epigenetic programming and reprogramming during development. Nat. Struct. Mol. Biol. 20(3), 282-289 (2013
7. Masaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, Rambukkana A. Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell 152(1-2), 51-67 (2013
8. Wolff CF Theoretica generationis. (1759
9. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 128(4), 669-681 (2007
10. Chodavarapu RK, Feng S, Bernatavichute YV et al. Relationship between nucleosome positioning and DNA methylation. Nature 466(7304), 388-392 (2010
11. Ferguson-Smith AC, Greally JM, Martienssen RA. Epigenomics. Springer, Berlin, Germany (2009
12. Ernst J, Kheradpour P, Mikkelsen TS et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473(7345), 43-49 (2011
13. Visel A, Rubin EM, Pennacchio LA. Genomic views of distant-Acting enhancers. Nature 461(7261), 199-205 (2009
14. Ostuni R, Piccolo V, Barozzi I et al. Latent enhancers activated by stimulation in differentiated cells. Cell 152(1-2), 157-171 (2013
15. Dunham I. An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414), 57-74 (2012
16. Shames DS, Minna JD, Gazdar AF. DNA methylation in health, disease, and cancer. Curr. Mol. Med. 7(1), 85-102 (2007
17. Pasque V, Jullien J, Miyamoto K, Halley-Stott RP, Gurdon JB. Epigenetic factors influencing resistance to nuclear reprogramming. Trends Genet. 27(12), 516-525 (2011
18. Jaenisch R. Stem cells, pluripotency and nuclear reprogramming. J. Thromb. Haemost. 7(Suppl. 1), 21-23 (2009
19. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007
20. Hanna J, Saha K, Pando B et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462(7273), 595-601 (2009
21. Kleinnijenhuis J, Quintin J, Preijers F et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl Acad. Sci. USA 109(43), 17537-17542 (2012
22. Swaim LE, Connolly LE, Volkman HE, Humbert O, Born DE, Ramakrishnan L. Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infect. Immun. 74(11), 6108-6117 (2006
23. Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: Macrophages, mast cells and neutrophils. Nat. Immunol. 12(11), 1035-1044 (2011
24. Murphy KM, Stockinger B. Effector T cell plasticity: Flexibility in the face of changing circumstances. Nat. Immunol. 11(8), 674-680 (2010
25. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat. Immunol. 11(10), 889-896 (2010
26. Murphy KP. Janeway's Immunobiology (7th Edition). Garland Science, London, UK (2008
27. Reiner SL. Epigenetic control in the immune response. Hum. Mol. Genet. 14 (Spec No 1), R41-R46 (2005
28. Bird JJ, Brown DR, Mullen AC et al. Helper T cell differentiation is controlled by the cell cycle. Immunity 9(2), 229-237 (1998
29. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14(3), 205-215 (2001
30. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2(12), 933-944 (2002
31. Martino DJ, Prescott SL. Silent mysteries: Epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease. Allergy 65(1), 7-15 (2010
32. Kogut MH, Chiang HI, Swaggerty CL, Pevzner IY, Zhou H. Gene expression analysis of Toll-like receptor pathways in heterophils from genetic chicken lines that differ in their susceptibility to Salmonella enteritidis. Front. Genet. 3, 121 (2012
33. Ansel KM, Lee DU, Rao A. An epigenetic view of helper T cell differentiation. Nat. Immunol. 4(7), 616-623 (2003
34. Lal G, Bromberg JS. Epigenetic mechanisms of regulation of FOXP3 expression. Blood 114(18), 3727-3735 (2009
35. Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 9(2), 91-105 (2009
36. Fernández-Morera JL, Calvanese V, Rodríguez-Rodero S, Menéndez-Torre E, Fraga MF. Epigenetic regulation of the immune system in health and disease. Tissue Antigens 76(6), 431-439 (2010
37. Bayarsaihan D. Epigenetic mechanisms in inflammation. J. Dent. Res. 90(1), 9-17 (2011
38. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: The key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 9(2), 83-89 (2009
39. Bocker MT, Hellwig I, Breiling A, Eckstein V, Ho AD, Lyko F. Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood 117(19), e182-e189 (2011
40. Ohkura N, Hamaguchi M, Morikawa H et al. T cell receptor stimulation-induced epigenetic changes and FOXP3 expression are independent and complementary events required for Treg cell development. Immunity 37(5), 785-799 (2012
41. Meissner A, Mikkelsen TS, Gu H et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454(7205), 766-770 (2008
42. Natoli G. Maintaining cell identity through global control of genomic organization. Immunity 33(1), 12-24 (2010
43. Del RM. Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes. Leukemia (2012
44. Elo LL, Järvenpää H, Tuomela S et al. Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming. Immunity 32(6), 852-862 (2010
45. Janson PCJ. Profiling of CD4(+) T cells with epigenetic immune lineage analysis. J. Immunol. 186(1), 92-102 (2011
46. Schoenborn JR, Dorschner MO, Sekimata M et al. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat. Immunol. 8(7), 732-742 (2007
47. Mikkelsen TS, Ku M, Jaffe DB et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448(7153), 553-560 (2007
48. Seita J, Weissman IL. Hematopoietic stem cell: Self-renewal versus differentiation. Wiley Interdiscip. Rev. Syst. Biol. Med. 2(6), 640-653 (2010
49. Kondilis-Mangum HD, Wade PA. Epigenetics and the adaptive immune response. Mol. Aspects Med. 34(4), 813-825 (2013
50. Ramírez J, Lukin K, Hagman J. From hematopoietic progenitors to B cells: Mechanisms of lineage restriction and commitment. Curr. Opin. Immunol. 22(2), 177-184 (2010
51. Zhang JLA. Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell 149(2), 467-482 (2012
52. Ramming A, Druzd D, Leipe J, Schulze-Koops H, Skapenko A. Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell development. Blood 119(20), 4665-4674 (2012
53. Zhang JW. Harnessing of the nucleosomeremodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis. Nature Immunol. 13(1), 86-94 (2012
54. Pham TH, Benner C, Lichtinger M et al. Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood 119(24), e161-e171 (2012
55. Barneda-Zahonero B, Roman-Gonzalez L, Collazo O, Mahmoudi T, Parra M. Epigenetic regulation of B lymphocyte differentiation, transdifferentiation, and reprogramming. Comp. Funct. Genomics 2012, 564381 (2012
56. Fernández-Sánchez A, Baragaño Raneros A, Carvajal Palao R et al. DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells. Epigenetics 8(1), 66-78 (2013
57. Suarez-Alvarez B, Rodriguez RM, Fraga MF, López-Larrea C. DNA methylation: A promising landscape for immune system-related diseases. Trends Genet. 28(10), 506-514 (2012
58. Bröske AM, Vockentanz L, Kharazi S et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat. Genet. 41(11), 1207-1215 (2009
59. Shaknovich R, Cerchietti L, Tsikitas L et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 118(13), 3559-3569 (2011
60. Reynaud D, Demarco IA, Reddy KL et al. Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat. Immunol. 9(8), 927-936 (2008
61. Decker T, Pasca di Magliano M, McManus S et al. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Immunity 30(4), 508-520 (2009
62. Kaiko GE, Horvat JC, Beagley KW, Hansbro PM Immunological decisionmaking: How does the immune system decide to mount a helper T-cell response? Immunology 123(3), 326-338 (2008
63. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. Helper T cell diversity and plasticity. Curr. Opin. Immunol. 24(3), 297-302 (2012
64. Akimzhanov AM, Yang XO, Dong C. Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J. Biol. Chem. 282(9), 5969-5972 (2007
65. Ansel KM, Djuretic I, Tanasa B, Rao A. Regulation of Th2 differentiation and IL4 locus accessibility. Annu. Rev. Immunol. 24, 607-656 (2006
66. Lee GR, Kim ST, Spilianakis CG, Fields PE, Flavell RA. T helper cell differentiation: Regulation by cis elements and epigenetics. Immunity 24(4), 369-379 (2006
67. Wei G, Wei L, Zhu J et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30(1), 155-167 (2009
68. Bowdridge S, Gause WC. Regulation of alternative macrophage activation by chromatin remodeling. Nat. Immunol. 11(10), 879-881 (2010
69. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 496(7446), 445-455 (2013
70. Fields PE, Lee GR, Kim ST, Bartsevich VV, Flavell RA. Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region. Immunity 21(6), 865-876 (2004
71. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 383(6603), 787-793 (1996
72. Murphy E, Shibuya K, Hosken N et al. Reversibility of T helper 1 and 2 populations is lost after long-Term stimulation. J. Exp. Med. 183(3), 901-913 (1996
73. Mullen AC, Hutchins AS, Villarino AV et al. Cell cycle controlling the silencing and functioning of mammalian activators. Curr. Biol. 11(21), 1695-1699 (2001
74. Takemoto N, Koyano-Nakagawa N, Yokota T, Arai N, Miyatake S, Arai K. Th2-specific DNase I-hypersensitive sites in the murine IL-13 and IL-4 intergenic region. Int. Immunol. 10(12), 1981-1985 (1998
75. Jaenisch R, Bird A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat. Genet. 33, 245-254 (2003
76. Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 4(3), 235-240 (2003
77. Weng NP, Araki Y, Subedi K. The molecular basis of the memory T cell response: Differential gene expression and its epigenetic regulation. Nat. Rev. Immunol. 12(4), 306-315 (2012
78. Oldstone MB. Molecular mimicry and autoimmune disease. Cell 50(6), 819-820 (1987
79. Cournoyer D, Caskey CT. Gene therapy of the immune system. Annu. Rev. Immunol. 11, 297-329 (1993
80. Fischer A, Cavazzana-Calvo M, De Saint Basile G et al. Naturally occurring primary deficiencies of the immune system. Annu. Rev. Immunol. 15, 93-124 (1997
81. Tada T. The immune system as a supersystem. Annu. Rev. Immunol. 15, 1-13 (1997
82. Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17, 781-828 (1999
83. Staudt LM, Brown PO. Genomic views of the immune system. Annu. Rev. Immunol. 18, 829-859 (2000
84. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: Why and where it occurs. Nat. Med. 7(8), 899-905 (2001
85. van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15(2), 294-309 (2002
86. Pardoll D. Does the immune system see tumors as foreign or self? Annu. Rev. Immunol. 21, 807-839 (2003
87. Portela A, Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 28(10), 1057-1068 (2010
88. Josefowicz SZ, Wilson CB, Rudensky AY Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. J. Immunol. 182(11), 6648-6652 (2009
89. Kuballa P, Nolte WM, Castoreno AB, Xavier RJ. Autophagy and the immune system. Annu. Rev. Immunol. 30, 611-646 (2012
90. Schmidt A, Oberle N, Krammer PH. Molecular mechanisms of Treg-mediated T cell suppression. Front. Immunol. 3, 51 (2012
91. de la Rica L. Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression. J. Autoimmunity 41, 6-16 (2013
92. Morris AC, Spangler WE, Boss JM. Methylation of class II trans-Activator promoter IV: A novel mechanism of MHC class II gene control. J. Immunol. 164(8), 4143-4149 (2000
93. Zika E, Fauquier L, Vandel L, Ting JP. Interplay among coactivator-Associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression. Proc. Natl Acad. Sci. USA 102(45), 16321-16326 (2005
94. Zika E, Ting JP. Epigenetic control of MHC-II: Interplay between CIITA and histone-modifying enzymes. Curr. Opin. Immunol. 17(1), 58-64 (2005
95. Accolla RS, De Lerma Barbaro A, Mazza S, Casoli C, De Maria A, Tosi G. The MHC class II transactivator: Prey and hunter in infectious diseases. Trends Immunol. 22(10), 560-563 (2001
96. Mehta NT, Truax AD, Boyd NH, Greer SF. Early epigenetic events regulate the adaptive immune response gene CIITA. Epigenetics 6(4), 516-525 (2011
97. Wright KL, Ting JP. Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol. 27(9), 405-412 (2006
98. Toossi Z. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J. Infect. Dis. 188(8), 1146-1155 (2003
99. Saifuddin M, Spear GT, Chang C, Roebuck KA. Expression of MHC class II in T cells is associated with increased HIV-1 expression. Clin. Exp. Immunol. 121(2), 324-331 (2000
100. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16(10), 2851-2860 (1997
101. Cho I, Blaser MJ. The human microbiome: At the interface of health and disease. Nat. Rev. Genet. 13(4), 260-270 (2012
102. Yoo EJ, Park SY, Cho NY, Kim N, Lee HS, Kang GH. Helicobacter pylori-infectionassociated CpG island hypermethylation in the stomach and its possible association with polycomb repressive marks. Virchows Arch. 452(5), 515-524 (2008
103. Arumugam M, Raes J, Pelletier E et al.; MetaHIT Consortium. Enterotypes of the human gut microbiome. Nature 473(7346), 174-180 (2011
104. Qin J, Li R, Raes J et al.; MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285), 59-65 (2010
105. Ogino S, Lochhead P, Chan AT et al. Molecular pathological epidemiology of epigenetics: Emerging integrative science to analyze environment, host, and disease. Mod. Pathol. 26(4), 465-484 (2013
106. Yamauchi M. Physical activity, tumor PTGS2 expression, and colorectal cancer survival: A molecular pathological epidemiology (MPE) approach. Cancer Epidemiol. Biomarkers Prev. 22(3), 474 (2013
107. Nishihara R, Chan AT, Ogino S. Smoking and colorectal cancer risk by tumor genetic and epigenetic subtypes: A molecular pathological epidemiology (MPE) study. Cancer Epidemiol. Biomarkers Prev. 22(3), 473 (2013
108. Zhou Y, Yuan J, Pan Y et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin. Immunol. 132(3), 362-370 (2009
109. Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J. Immunol. 174(10), 6212-6219 (2005
110. Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179(9), 6352-6358 (2007
111. Lu Q, Kaplan M, Ray D et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 46(5), 1282-1291 (2002
112. Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol. 172(6), 3652-3661 (2004
113. Luo Y, Zhao M, Lu Q. Demethylation of promoter regulatory elements contributes to CD70 overexpression in CD4+ T cells from patients with subacute cutaneous lupus erythematosus. Clin. Exp. Dermatol. 35(4), 425-430 (2010
114. Cao R, Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine[thinsp]27 in histone H3. Curr. Opin. Genet. Dev. 14, 155-164 (2004
115. Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T. Identification of silencing of nine genes in human gastric cancers. Cancer Res. 62(22), 6645-6650 (2002
116. Strickland FM, Richardson BC. Epigenetics in human autoimmunity. Epigenetics in autoimmunity -DNA methylation in systemic lupus erythematosus and beyond. Autoimmunity 41(4), 278-286 (2008
117. Strickland FM, Hewagama A, Lu Q et al. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J. Autoimmun. 38(2-3), J135-J143 (2012
118. Carson WF, Cavassani KA, Dou Y, Kunkel SL. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 6(3), 273-283 (2011
119. Hamon MA, Cossart P. Histone modifications and chromatin remodeling during bacterial infections. Cell Host Microbe 4(2), 100-109 (2008
120. Wen H, Dou Y, Hogaboam CM, Kunkel SL. Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood 111(4), 1797-1804 (2008
121. Verma M, Seminara D, Arena FJ, John C, Iwamoto K, Hartmuller V. Genetic and epigenetic biomarkers in cancer: Improving diagnosis, risk assessment, and disease stratification. Mol. Diagn. Ther. 10(1), 1-15 (2006
122. McDevitt MA. Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies. Semin. Oncol. 39(1), 109-122 (2012
123. Valinluck V, Sowers LC Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 67(3), 946-950 (2007
124. Stenvinkel P, Karimi M, Johansson S et al. Impact of inflammation on epigenetic DNA methylation -A novel risk factor for cardiovascular disease? J. Intern. Med. 261(5), 488-499 (2007
125. Kaufmann SHE. Chapter 12: T-Zellen. Medizinische Mikrobiologie und Infektiologie. Suerbaum SB, Hahn H, Burchard G-D, Kaufmann SHE, Schulz TF (Eds). Springer-Verlag, Berlin, Germany, 74-88 (2012
126. Waddington CH. The strategy of the genes: A discussion of some aspects of theoretical biology. Allen & Unwin (1957